Real-time enrollment status for this advanced pancreatic ductal adenocarcinoma clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 12:37 PM UTC
| NCT Number | NCT07619521 |
| Recruiting Status | Recruiting |
| Condition | Advanced Pancreatic Ductal Adenocarcinoma |
| Phase | PHASE1 |
| Target Enrollment | 31 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | September 22, 2026 (3 weeks ago) |
As of October 17, 2026: Clinical trial NCT07619521 is currently recruiting participants. This phase1 study for advanced pancreatic ductal adenocarcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07619521 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07619521 was last updated 3 weeks ago (September 22, 2026). HelloStudys verifies this status automatically.